Mosaic ImmunoEngineering Expands Its Modular Vaccine Platform (MVP) Through New Technology Licensing Agreement with the University of California San Diego

September 21, 2021 8:00 AM

- Licensed Candidates Hold Potential to Address Emerging SARS-CoV-2 and other Infectious Diseases Including Human and Veterinary Applications -- Data Supporting the Potential of Lead Vaccine Candidates was Funded Through Competitive Federal Grants and has Been Published in Peer Reviewed Scientific Publications -- MVP Combines Protein Nanoparticle-Based Adjuvants Linked to Infectious Disease Peptides for Rapid Development of Thermally Stable and...

Read more

Helix BioPharma Corp. Announces Appointment of Interim Chief Executive Officer

September 20, 2021 5:23 PM

RICHMOND HILL, ON / ACCESSWIRE / September 20, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Company's Chairman of the Board, Prof. Dr. Slawomir Majewski, will immediately assume the role of Interim CEO while the Company continues to identify and evaluate candidates.About Helix BioPharma...

Read more

Bakhu Holdings, Corp. Announces Appointment of Teddy C. Scott As CEO and Chair of the Board

September 20, 2021 8:43 AM

LONG BEACH, CA / ACCESSWIRE / September 20, 2021 / Bakhu Holdings, Corp. (OTC PINK:BKUH) today announced that Teddy C. Scott, 55, Ph.D., J.D., has accepted positions as CEO and Chair of the Board for the cell replication technology company. Scott, known as "Teddy" throughout the industry, has more than 20 years in biotechnology research, intellectual property law and the cannabis industry.Teddy has been recognized for his leadership in the...

Read more

Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients

September 20, 2021 8:00 AM

Study unblinded due to strong efficacy signal for 28-day mortality endpointCritically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over Standard of CareData monitoring board recommends continuation to confirmatory Phase 3 studyTORONTO, ON / ACCESSWIRE / September 20, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases,...

Read more

Medspresso Announces Additional Speciality Coffees To The Range

September 17, 2021 8:30 AM

CAPE TOWN, SA / ACCESSWIRE / September 17, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update:M2Bio Sciences Food and Beverage is thrilled to launch the Medspresso CBD Infused Organic Whole Bean and Ground Coffee Range. The range will consist of two Speciality...

Read more

ITOCO Receives Final Agreement on an Initial 1,014 Hectares of Nopal Cactus Plantations in Mexico for the Purpose of Carbon Credit Capture; and Will Attend "Dia Internacional Del Nopal En Mexico"

September 16, 2021 7:30 AM

TORONTO, ON / ACCESSWIRE / September 16, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to have received final signatures on an initial 1,014 hectares of Nopal Cactus Plantations in State of Mexico and Hidalgo State, Mexico from 125 individual farmers.ITOCO has applied to "Verra Standard (VCS)" for the certification of approximately US $750k in Carbon Credits based on the extractive properties of the Nopal Cactus plant vis a vis Carbon on this...

Read more

Vaccine Developer Intravacc Launches Hybrid Business Model to Drive Innovation and Growth

September 16, 2021 7:00 AM

Hybrid model: CDMO services and development of own vaccine pipelineIntravacc will also put emphasis on the therapeutic vaccine marketIntravacc's own vaccine portfolio will mainly focus on intranasal administrationIntravacc launches promotional campaign for funding of phase I clinical trials of Avacc 10 nasal spray vaccineBILTHOVEN, THE NETHERLANDS / ACCESSWIRE / September 16, 2021 / Intravacc, a global leader in translational research and the...

Read more

RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents

September 16, 2021 6:00 AM

Canadian granting agency MITACS commits to three years of funding for the project's second stage to optimize certain proprietary microcarrier technologies for use in RepliCel's cell therapy manufacturingRepliCel signs an Option to License agreement related to a filed US patent applicationVANCOUVER, BC / ACCESSWIRE / September 16, 2021 / RepliCel Life Sciences Inc. (OTCQB:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company...

Read more

NovAccess Global, Inc. CEO Interviewed On MoneyTV

September 15, 2021 9:00 AM

CLEVELAND, OH / ACCESSWIRE / September 15, 2021 / NovAccess Global, Inc. (OTC PINK:XSNX) announced Dr. Dwain Irvin's interview on MoneyTV aired on September 11, 2021.MoneyTV has been in the business for 25 years, reaching 200 million homes in 75 countries. Dr. Dwain Irvin's interview can be watched here.https://novaccessglobal.com/Dr. Dwain Irvin was interviewed by Don Baillargeon, a broadcast industry veteran of more than 30 years. Don...

Read more

Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021

September 15, 2021 8:05 AM

Conference call with live video webcast to be held on Tuesday, September 21st at 4:30 p.m. ETIRVINE, CA / ACCESSWIRE / September 15, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Hancock Jaffe management will host a corporate update conference call with a live video webcast on Tuesday, September 21, 2021 at...

Read more

DiviTum(R)TKa Results from SWOG Study Published in Clinical Cancer Research

September 15, 2021 2:20 AM

UPPSALA, SE / ACCESSWIRE / September 15, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announces that DiviTum®TKa results from an analysis of samples from the large SWOG S0226 study have been published in the highly ranked peer-reviewed scientific journal Clinical Cancer Research, published by the American Association for Cancer Research (AACR). The strong results support using...

Read more

Black Bird Biotech Announces First Sales of Disruptive Plant-Based MiteXstreamTM Biopesticide, Prepares for Fourth Quarter Marketing Push Within Cannabis Industry

September 14, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 14, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that it had achieved the first sales of its game-changing biopesticide, MiteXstreamTM, as it accelerates its planned fourth quarter sales and marketing efforts that are intended to bring much-needed crop protection to the dynamic cannabis industry, one that is expected to grow to...

Read more

Promising DiviTumTKa Results from BioItaLEE Study Presented at ESMO

September 14, 2021 2:20 AM

UPPSALA, SE / ACCESSWIRE / September 14, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announces that DiviTumTKa results from the large BioItaLEE study will be presented as a poster during the European Society for Medical Oncology (ESMO) meeting 16 to 21 September 2021. The results strengthen the potential of DiviTum ® TKa as a treatment monitoring devise for CDK4/6 inhibitor...

Read more

Applied UV Continues International Expansion with Airocide(R) Installation in South Korean Schools

September 13, 2021 8:30 AM

Installations in nearly 100 school dedicated observation roomsAirocide® technology helps schools reopen safely and allow for the safe return to campusMOUNT VERNON, NY / ACCESSWIRE / September 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air...

Read more

Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product

September 13, 2021 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / September 13, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH). In keeping with management's commitment to continue implementation of Oncology Pharma's ("the Company") capital formation plan, the Company has obtained, received and segregated all funds necessary to execute the first phase of the development project of a nanoemulsion of dactinomycin, with the initial tranche released as scheduled.Management of Oncology...

Read more

Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference

September 13, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that its management team will participate in Lake Street's 5th Annual Best Ideas Growth Conference.September 14-15, 2021Lake Street's 5th Annual Best Ideas Growth ConferenceManagement teams from over 100 dynamic small-cap publicly traded...

Read more

Biovica Provides Update on FDA Application Process

September 13, 2021 2:30 AM

UPPSALA, SE / ACCESSWIRE / September 13, 2021 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announced that the company's expected timeline for its updated 510(k)-application to the US Food and Drug Administration (FDA) has been prolonged due to delay in response from FDA.As Biovica is still waiting for required feedback from the FDA the company has not been able to submit its updated...

Read more

Applied UV to Present at the Virtual H.C. Wainwright Global Investor Conference

September 10, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 10, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced that Q Saeed, CEO of Applied UV, will present at the virtual H.C. Wainwright...

Read more

Viewpoint Molecular Targeting(TM) Receives FDA Clearance of Investigational New Drug Application for Phase 1 Imaging Study for VMT-a-NET for Neuroendocrine Tumors

September 9, 2021 10:00 AM

VMT-𝛼-NET Phase 1 imaging study to be followed by Phase 1/2a therapy study for the treatment of neuroendocrine tumors being conducted at the University of IowaPreclinical efficacy results demonstrated VMT-𝛼-NET to significantly inhibit tumor growth and improve survival compared to untreated controlsVMT-𝛼-NET imaging study provisional results expected in Q4 2021CORALVILLE, IA / ACCESSWIRE / September 9, 2021 / Viewpoint Molecular Targeting,...

Read more

Ichor Therapeutics Rebrands as Ichor Life Sciences, Focuses on Contract Research Work and Strategic Programs

September 9, 2021 9:00 AM

LAFAYETTE, NY / ACCESSWIRE / September 9, 2021 / Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences' emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette and Potsdam, both located in the Finger Lakes intellectual corridor of upstate New York.Ichor Life Sciences services customers in numerous...

Read more